全文获取类型
收费全文 | 26713篇 |
免费 | 2836篇 |
国内免费 | 1300篇 |
专业分类
耳鼻咽喉 | 307篇 |
儿科学 | 398篇 |
妇产科学 | 455篇 |
基础医学 | 2820篇 |
口腔科学 | 505篇 |
临床医学 | 3415篇 |
内科学 | 4554篇 |
皮肤病学 | 324篇 |
神经病学 | 1577篇 |
特种医学 | 770篇 |
外国民族医学 | 8篇 |
外科学 | 2857篇 |
综合类 | 3874篇 |
现状与发展 | 4篇 |
一般理论 | 14篇 |
预防医学 | 2523篇 |
眼科学 | 656篇 |
药学 | 2495篇 |
15篇 | |
中国医学 | 1186篇 |
肿瘤学 | 2092篇 |
出版年
2024年 | 59篇 |
2023年 | 307篇 |
2022年 | 540篇 |
2021年 | 906篇 |
2020年 | 678篇 |
2019年 | 676篇 |
2018年 | 777篇 |
2017年 | 722篇 |
2016年 | 745篇 |
2015年 | 962篇 |
2014年 | 1256篇 |
2013年 | 1329篇 |
2012年 | 1734篇 |
2011年 | 1795篇 |
2010年 | 1250篇 |
2009年 | 1109篇 |
2008年 | 1376篇 |
2007年 | 1487篇 |
2006年 | 1379篇 |
2005年 | 1320篇 |
2004年 | 1293篇 |
2003年 | 1466篇 |
2002年 | 1353篇 |
2001年 | 1061篇 |
2000年 | 730篇 |
1999年 | 598篇 |
1998年 | 290篇 |
1997年 | 314篇 |
1996年 | 231篇 |
1995年 | 201篇 |
1994年 | 170篇 |
1993年 | 122篇 |
1992年 | 214篇 |
1991年 | 188篇 |
1990年 | 205篇 |
1989年 | 144篇 |
1988年 | 160篇 |
1987年 | 156篇 |
1986年 | 130篇 |
1985年 | 134篇 |
1984年 | 100篇 |
1983年 | 82篇 |
1982年 | 70篇 |
1979年 | 91篇 |
1978年 | 70篇 |
1975年 | 56篇 |
1974年 | 53篇 |
1973年 | 69篇 |
1972年 | 55篇 |
1969年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
目的:了解新型冠状病毒肺炎(COVID-19)患者出院后的生活质量及其影响因素,为优化早期干预方案,预防社区生活受限,制定相应社区康复措施提供依据。方法:选择2020年3—4月在武汉华润武钢总医院治愈出院的COVID-19患者57例,于2020年4—5月通过"问卷星"平台采用简明健康状况调查量表(SF-12V2)调查患者的生活质量;采用焦虑自评量表(SAS)调查患者的焦虑状态;采用抑郁自评量表(SDS)调查患者的抑郁状态;采用呼吸困难指数量表(mMRC)调查患者的呼吸困难程度。比较不同特征COVID-19患者生活质量的差异;分析患者生活质量与焦虑、抑郁和呼吸困难程度的相关性及其相关的影响因素。结果:共发放57份调查问卷,剔除重复及无效问卷3份,获得有效问卷54份,问卷有效率达94.74%。(1)COVID-19出院后患者生活质量情况:生理总评分和心理总评分分别为(37.02±12.32)分、(38.46±14.42)分;呼吸困难等级0~3级的分别为3例(5.56%)、45例(83.33%)、5例(9.26%)、1例(1.85%);有19例(35.19%)存在焦虑情绪(SAS≥50分)和抑郁情绪(SDS≥53分)。(2)不同特征COVID-19患者生活质量比较:不同疾病分型的患者在生理总评分方面差异有统计学意义(P<0.05)。(3)生活质量与焦虑、抑郁和呼吸困难程度的相关性分析:Pearson相关分析结果显示,SF-12V2生理总评分与焦虑程度(r=-0.34,P=0.011)和呼吸困难程度(r=-0.39,P=0.003)之间存在负相关性,SF-12V2心理总评分与焦虑程度(r=-0.46,P=0.001)和抑郁程度(r=-0.40,P=0.002)之间存在负相关性。(4)COVID-19患者生活质量的影响因素分析:多元线性回归分析显示,性别(β=8.27)、抑郁程度(β=-0.34)和疾病分型(β=-11.68)是患者SF-12V2生理总评分的重要决定因素(P<0.05);焦虑程度(β=-0.62)是患者SF-12V2心理总评分的重要决定因素(P<0.05)。结论:COVID-19出院患者存在呼吸困难、焦虑抑郁情绪和生活质量下降的问题;性别、疾病分型、抑郁程度和焦虑程度是COVID-19患者生活质量下降的重要因素。COVID-19患者(特别是女性患者和重型患者)出院后要尽早进行抑郁症和焦虑症的筛查和干预,减少患者负性情绪,鼓励患者适当参与康复训练,提高呼吸功能,从而促进生活质量提高。 相似文献
4.
5.
6.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
7.
8.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120
Objective
The teaching hospital of Nancy, France, implemented a specific multidisciplinary care pathway (French acronym AMDPL) to improve the management of patients presenting with Lyme borreliosis (LB) suspicion. We aimed to assess the first year of activity of this care pathway.Patients and methods
We included all patients managed in the AMDPL pathway from November 1, 2016 to October 31, 2017. The first step was a dedicated Lyme disease consultation with an infectious disease specialist. Following this consultation, the LB diagnosis was either confirmed and adequate treatment was prescribed, or a differential diagnosis was established and patients received adequate management, or further investigations were required and patients were offered multidisciplinary management as part of a day hospitalization.Results
A total of 468 patients were included. LB diagnosis was confirmed in 15% of patients (69/468), 49% of patients received a differential diagnosis, and 26% (122/468) of patients had the LB diagnosis ruled out without receiving any other diagnosis.Conclusions
This is to our knowledge the first multidisciplinary center implemented in France for the management of patients presenting with LB suspicion related to polymorphous signs and symptoms. Several diagnoses could be confirmed or corrected, although some symptoms and complaints could not be explained. This cohort could improve our knowledge of LB and its differential diagnoses. 相似文献9.
10.
新形势下八年制医学教育的再思考 《医学教育管理》2020,6(5):421-425
新形势下,健康中国建设和我国卫生事业发展迫切需要具有国际竞争力的医学科学家和领军人才。在现行医学教育体系中,培养具有国际竞争力的未来医学科学家和领军人才是八年制医学教育的必然选择。创新八年制医学人才培养模式应汲取长学制试办经验,直面现存问题,聚焦创新能力和创新精神,构建以研究为基础的八年制医学人才培养模式,确立“目标引领、厚植基础、面向临床、聚集创新”的办学原则,为我国卫生事业培养具有国际竞争力的未来领军人才。 相似文献